Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Current Assets (2016 - 2025)

Wave Life Sciences' Current Assets history spans 11 years, with the latest figure at $614.8 million for Q4 2025.

  • For Q4 2025, Current Assets rose 91.89% year-over-year to $614.8 million; the TTM value through Dec 2025 reached $614.8 million, up 91.89%, while the annual FY2025 figure was $614.8 million, 91.89% up from the prior year.
  • Current Assets reached $614.8 million in Q4 2025 per WVE's latest filing, up from $215.5 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $614.8 million in Q4 2025 to a low of $98.5 million in Q4 2022.
  • Average Current Assets over 5 years is $215.6 million, with a median of $189.6 million recorded in 2021.
  • Peak YoY movement for Current Assets: crashed 39.39% in 2022, then soared 138.87% in 2023.
  • A 5-year view of Current Assets shows it stood at $162.6 million in 2021, then tumbled by 39.39% to $98.5 million in 2022, then skyrocketed by 138.87% to $235.4 million in 2023, then skyrocketed by 36.12% to $320.4 million in 2024, then surged by 91.89% to $614.8 million in 2025.
  • Per Business Quant, the three most recent readings for WVE's Current Assets are $614.8 million (Q4 2025), $215.5 million (Q3 2025), and $223.6 million (Q2 2025).